Current scenario and future prospect of scabies treatment: A comprehensive review

Abstract

Scabies is a common skin condition, cause by the mite known as Sarcoptes Scabiei. Every year, 150–200 million people worldwide suffer from scabies. Small children are most vulnerable to scabies, which is most prevalent in congested, unsanitary living environments. It can transfer both directly from person to person and indirectly through contact with contaminated things. Scabies results in a highly irritating host immunological reaction. Impetigo and other secondary bacterial skin infections might result from scratching the wounds. It was officially classified as a neglected tropical illness by the World Health Organization in 2017. This review gives an overview of all the available therapy to treat scabies, and recent advancements in the management of scabies treatment in preclinical as well as clinical trials.